APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Walker, Brian A., Wardell, Christopher P., Murison, Alex, Boyle, Eileen M., Begum, Dil B., Dahir, Nasrin M., Proszek, Paula Z., Melchor, Lorenzo +13 more·2015·Nature Communications
DOI 10.1038/ncomms7997

Cited by (313)

Items 301–313 of 313

  1. Marqueurs moléculaires d’intérêt pronostique et thérapeutique chez les patients atteints de lymphome à cellules du manteau
    Yannick Le Bris · 2020
  2. The genetic architecture of plasma cell disorders
    Eileen Mary Boyle · 2020 · theses.fr (ABES)
  3. Dissecting the role of long non-coding RNA in multiple myeloma
    Simone Zocchi · 2024 · theses.fr (ABES)
  4. Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications
    María Carretero-Fernández, Antonio José Cabrera-Serrano, Lucía Ruiz-Durán, Mariam Ibáñez, Marco Bonilla, Francisco Mesa, Juan Francisco Gutiérrez‐Bautista, Rachid Chahboun, Fernando J. Reyes‐Zurita, Joaquín Martínez‐López et al. · 2026 · Translational Oncology
  5. High-Risk Multiple Myeloma: Redefining Risk and Rethinking Therapy
    Gareth John Morgan, Dennis D. Lee, Nisha S. Joseph, Sagar Lonial, Paula Rodríguez‐Otero, Jesus San-Miguel · 2026 · American Society of Clinical Oncology Educational Book
  6. Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease
    Noor Ul Ain, Noffar Bar, Lilu Guo, Katherine Klinger, Punita Gupta, Atta Ur Rahman, Ruhua Yang, Yanhong Deng, Natalia Neparidze, Shiny Nair et al. · 2026 · American Journal of Hematology
  7. When Myeloma Escapes the Bone Marrow: Extramedullary Disease in the Immunotherapy Era
    Aimaz Afrough, Christen M. Dillard, Anne Alsup, J.H. Lee, Samer Al Hadidi, Aishwarya Sannareddy, Pearl Rajan Abraham, Laura Turer, Danai Dima, Adeel M. Khan et al. · 2026 · Cancers
  8. Using electrochemical sensors to analyze the diagnostic role of IGHA1 macromolecules and immunoglobulin markers in multiple myeloma: single-cell transcriptomic analysis of plasma cell heterogeneity
    Jiaheng Wang, Gang Wang, Linjuan Xu, Hongwei Kong, Wenping Wu · 2026 · Microchemical Journal
  9. A single-cell atlas of multiple myeloma defines malignant archetypes and proliferative states
    Mor Zada, Anna Kurilovich, Noam Shapira, Shuang-Yin Wang, Reut Sharet-Eshed, Shlomit Kfir‐Erenfeld, Miriam Schlossberg, Elina Zorde, Nathalie Asherie, Chamutal Gur et al. · 2026 · Nature Genetics
  10. Unraveling the lexicon of complex mutational phenomena in human cancers
    Ting Yang, Erik N. Bergstrom, Stanley Clarke, Marcin B. Imielinski, Ludmil B. Alexandrov · 2026 · Nature Cancer
  11. Risk Stratification in Myeloma
    Anaïs Schavgoulidze, Jill Corre · 2026 · The Cancer Journal
  12. Pan-Cancer APOBEC Mutagenesis, Immune Microenvironment, and Clinical Outcome: A Comprehensive Multi-Omics Analysis of All Ten Family Members Across 9653 TCGA Tumors
    Sairos Ghniem, Ilias Georgakopoulos‐Soares, Apostolos Zaravinos · 2026 · International Journal of Molecular Sciences
  13. Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy
    Magrangeas, Florence, Cherkaoui, Mia, Bessonneau-Gaborit, Victor, Derrien, Jennifer, Chevalier, Céline, Guérin-Charbonnel, Catherine, Diamond, Benjamin, Samur, Mehmet Kemal, Intergroupe Francophone du Myélome (IFM), Hulin, Cyrille et al. · 2026 · Nature Medicine